Literature DB >> 32255628

PTP1B-Inhibiting Branched-Chain Fatty Acid Dimers from Eremophila oppositifolia subsp. angustifolia Identified by High-Resolution PTP1B Inhibition Profiling and HPLC-PDA-HRMS-SPE-NMR Analysis.

Hans Albert Pedersen1, Chi Ndi2, Susan J Semple2, Bevan Buirchell3, Birger Lindberg Møller4, Dan Staerk1.   

Abstract

Ten new branched-chain fatty acid (BCFA) dimers with a substituted cyclohexene structure, five new monomers, and two known monomers, (2E,4Z,6E)-5-(acetoxymethyl)tetradeca-2,4,6-trienoic acid and its 5-hydroxymethyl analogue, were identified in the leaf extract of Eremophila oppositifolia subsp. angustifolia using a combination of HPLC-PDA-HRMS-SPE-NMR analysis and semipreparative-scale HPLC. The dimers could be classified as three types of Diels-Alder reaction products formed between monomers at two different sites of unsaturation of the dienophile. Two of the monomers represent potential biosynthetic intermediates of branched-chain fatty acids. Several compounds were found by high-resolution bioactivity profiling to inhibit PTP1B and were purified subsequently by semipreparative-scale HPLC. The dimers were generally more potent than the monomers with IC50 values ranging from 2 to 66 μM, compared to 38-484 μM for the monomers. The ten fatty acid dimers represent both a novel class of compounds and a novel class of PTP1B inhibitors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32255628     DOI: 10.1021/acs.jnatprod.0c00070

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Navigating through chemical space and evolutionary time across the Australian continent in plant genus Eremophila.

Authors:  Oliver Gericke; Rachael M Fowler; Allison M Heskes; Michael J Bayly; Susan J Semple; Chi P Ndi; Dan Staerk; Claus J Løland; Daniel J Murphy; Bevan J Buirchell; Birger Lindberg Møller
Journal:  Plant J       Date:  2021-09-16       Impact factor: 7.091

Review 2.  Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants.

Authors:  Gerardo Mata-Torres; Adolfo Andrade-Cetto; Fernanda Espinoza-Hernández
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

3.  Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock.

Authors:  Malene J Petersen; Xamuel L Lund; Susan J Semple; Bevan Buirchell; Henrik Franzyk; Michael Gajhede; Kenneth T Kongstad; Jan Stenvang; Dan Staerk
Journal:  Biomolecules       Date:  2021-10-18

Review 4.  Biodiscoveries within the Australian plant genus Eremophila based on international and interdisciplinary collaboration: results and perspectives on outstanding ethical dilemmas.

Authors:  Susan J Semple; Dan Staerk; Bevan J Buirchell; Rachael M Fowler; Oliver Gericke; Louise Kjaerulff; Yong Zhao; Hans Albert Pedersen; Malene J Petersen; Line Fentz Rasmussen; Emilie Kold Bredahl; Gustav Blichfeldt Pedersen; Laura Mikél McNair; Chi P Ndi; Nikolaj Lervad Hansen; Allison M Heskes; Michael J Bayly; Claus J Loland; Nanna Heinz; Birger Lindberg Møller
Journal:  Plant J       Date:  2022-07-23       Impact factor: 7.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.